Latest Hormone Studies & News Bulletins
National Institutes Of Health
News Release: Tuesday, July 9, 2002
NHLBI Stops Trial of Estrogen Plus Progestin Due to Increased Breast Cancer Risk, Lack of Overall Benefit
JAMA Study: Hormone Replacement Therapy in Relation to Breast Cancer
Increased by 60% to 85% in recent long-term users of HRT
U.S. Food and Drug Administration of Center for Drug Evaluation and Research
FDA Statement on the Results of the Women's Health Initiative (8/13/2002) Women's Health Initiative (WHI) Results.
Signal Need for Reassessment of Risks and Benefits of Conjugated Equine Estrogens/medroxyprogesterone Acetate (Prempro) in Postmenopausal Women.
FDA Approves New Labeling and Provides New Advice to Postmenopausal Women Who Use or Who Are Considering Using Estrogen and Estrogen With Progestin
Top 10 Reasons to get off Synthetic Hormones
Osteoporosis Update
Progesterone and Men
Prostate Cancer Research
Hormones and Your Heart
Eliminating Hot Flashes